​

Accendra Health (ACH) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

ACH Stock Forecast

Accendra Health (ACH) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $5.00 and a low of $3.00. This represents a 68.07% increase from the last price of $2.38.

ACH Stock Rating

Accendra Health stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (20.00%), 10 Hold (66.67%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 2 10 3 Strong Sell Sell Hold Buy Strong Buy

ACH Price Target Upside V Benchmarks

TypeNameUpside
StockAccendra Health68.07%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks13.08%

Price Target Trends

1M3M12M
# Anlaysts126
Avg Price Target$3.00$4.00$6.50
Last Closing Price$2.38$2.38$2.38
Upside/Downside26.05%68.07%173.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-22-26
Feb, 26-22-26
Jan, 26-22-26
Dec, 25-22-26
Nov, 25-22-26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 22, 2026Kevin CaliendoUBS$3.00$2.6114.94%26.05%
Jan 06, 2026Eric ColdwellRobert W. Baird$5.00$9.04-44.69%110.08%
Nov 03, 2025Kevin CaliendoUBS$4.00$3.970.76%68.07%
Aug 13, 2025Kevin CaliendoUBS$7.00$5.4727.97%194.12%
Aug 11, 2025Michael MinchakJ.P. Morgan$10.00$7.0941.04%320.17%
Aug 08, 2025Eric ColdwellRobert W. Baird$10.00$7.0941.04%320.17%
Nov 05, 2024Eric ColdwellRobert W. Baird$14.00$11.8018.64%488.24%
Sep 23, 2024Eric ColdwellRobert W. Baird$19.00$16.0818.16%698.32%
Jun 25, 2024Michael ChernyLeerink Partners$17.00$15.0013.33%614.29%
Jun 25, 2024Eric ColdwellRobert W. Baird$20.00$16.1723.69%740.34%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 22, 2026UBSBuyBuyhold
Jan 05, 2026Bank of America SecuritiesUnderperformUnderperformhold
Nov 03, 2025UBSBuyNeutraldowngrade
Nov 03, 2025UBSBuyBuydowngrade
Aug 12, 2025CitigroupBuyBuyhold
Aug 11, 2025UBSBuyBuyhold
Jul 19, 2024CitigroupNeutralBuyupgrade
Jun 25, 2024BarclaysEqual-WeightEqual-Weighthold
May 06, 2024Bank of America SecuritiesUnderperformUnderperformhold
Apr 29, 2024CitigroupNeutralNeutralhold

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-4.73$-14.31----
Avg Forecast$1.50$1.01$0.96$1.18$1.26$1.42
High Forecast$1.54$1.04$0.99$1.21$1.29$1.46
Low Forecast$1.47$0.96$0.94$1.15$1.23$1.39
Surprise %-415.33%-1516.83%----

Revenue Forecast

$3B $4B $6B $8B $9B $11B Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$10.70B$2.76B----
Avg Forecast$10.69B$2.77B$2.62B$2.75B$3.04B$9.47B
High Forecast$10.91B$2.83B$2.63B$2.75B$3.10B$9.67B
Low Forecast$10.53B$2.73B$2.61B$2.75B$2.99B$9.33B
Surprise %0.11%-0.20%----

Net Income Forecast

$-2B $-1B $-700M $-300M $100M $500M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-362.69M$-1.10B----
Avg Forecast$4.59M$3.08M$2.96M$3.61M$3.85M$4.36M
High Forecast$4.72M$3.21M$3.05M$3.71M$3.96M$4.48M
Low Forecast$4.50M$2.96M$2.90M$3.54M$3.78M$4.27M
Surprise %-7999.01%-35823.02%----

ACH Forecast FAQ

Is Accendra Health stock a buy?

Accendra Health stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 10 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Accendra Health is a neutral investment for most analysts.

What is Accendra Health's price target?

Accendra Health's price target, set by 15 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $3 at the low end to $5 at the high end, suggesting a potential 68.07% change from the previous closing price of $2.38.

How does Accendra Health stock forecast compare to its benchmarks?

Accendra Health's stock forecast shows a 68.07% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (13.08%).

What is the breakdown of analyst ratings for Accendra Health over the past three months?

  • March 2026: 0% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 33.33% Strong Sell.
  • February 2026: 0% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 33.33% Strong Sell.
  • January 2026: 0% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 33.33% Strong Sell.

What is Accendra Health’s EPS forecast?

Accendra Health's average annual EPS forecast for its fiscal year ending in December 2026 is $0.96, marking a -106.71% decrease from the reported $-14.31 in 2025. Estimates for the following years are $1.18 in 2027, $1.26 in 2028, and $1.42 in 2029.

What is Accendra Health’s revenue forecast?

Accendra Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.62B, reflecting a -5.28% decrease from the reported $2.76B in 2025. The forecast for 2027 is $2.75B, followed by $3.04B for 2028, and $9.47B for 2029.

What is Accendra Health’s net income forecast?

Accendra Health's net income forecast for the fiscal year ending in December 2026 stands at $2.96M, representing a -100.27% decrease from the reported $-1.101B in 2025. Projections indicate $3.61M in 2027, $3.85M in 2028, and $4.36M in 2029.